Glaucoma Treatment Options: Drops, Laser and Surgery

Medicated eye drops remain the most common starting point for glaucoma management, and several classes of drops target eye pressure through different mechanisms.

Prostaglandin analogs, such as latanoprost, travoprost, and bimatoprost, are among the most widely prescribed glaucoma drops. They work by increasing the outflow of aqueous humor (the clear fluid inside your eye) through a secondary drainage pathway called the uveoscleral route. Most patients use these drops once daily at bedtime, and they typically lower IOP by 25 to 35 percent. You can learn more about individual drop classes in our complete glaucoma eye drop medication guide.

Beta-blocker eye drops, such as timolol, reduce eye pressure by slowing the production of aqueous humor in the ciliary body. They are usually applied once or twice daily and can lower pressure by approximately 20 to 25 percent. Because beta-blockers can affect heart rate and breathing, our glaucoma specialists review your medical history carefully before prescribing them, particularly if you have asthma, heart disease, or low blood pressure.

Alpha-adrenergic agonists, including brimonidine, work through a dual mechanism. They reduce aqueous humor production while also enhancing fluid outflow. These drops are commonly used as an adjunct to prostaglandins or beta-blockers when a single medication is not enough to reach the target pressure.

Carbonic anhydrase inhibitors (CAIs), such as dorzolamide and brinzolamide, lower eye pressure by decreasing aqueous humor production. They are available as topical eye drops used two to three times daily, or in oral form for more aggressive short-term pressure reduction. Oral CAIs can cause systemic side effects including tingling in the fingers and toes, fatigue, and changes in taste, so they are generally reserved for situations that require rapid pressure control.

Rho kinase inhibitors, such as netarsudil, represent a newer class of glaucoma medication that works by relaxing cells in the trabecular meshwork, the eye's primary drainage tissue. This helps fluid exit the eye more easily. Many patients benefit from combination drops that contain two medications in a single bottle, which simplifies the daily routine and improves adherence. Common combinations pair a prostaglandin with a rho kinase inhibitor or a beta-blocker with a carbonic anhydrase inhibitor.

SLT is a quick, in-office laser procedure that targets pigmented cells in the trabecular meshwork to improve your eye's natural fluid drainage. The treatment typically takes five to ten minutes per eye and uses low-energy laser pulses that do not cause thermal damage to surrounding tissue. Most patients can resume normal activities the same day, and the pressure-lowering effect usually becomes apparent within a few weeks.

MIGS refers to a group of surgical procedures that use tiny devices or micro-incisions to improve aqueous humor outflow with less risk and faster recovery compared to traditional glaucoma surgery. These procedures are best suited for patients with mild-to-moderate open-angle glaucoma and are frequently performed during cataract surgery. While MIGS procedures generally produce a moderate pressure reduction, they can meaningfully reduce or eliminate dependence on daily eye drops for many patients.

The choice of treatment depends on several factors, including the type and severity of your glaucoma, your current eye pressure, the health of your optic nerve, how well you tolerate medications, and your lifestyle preferences. Our glaucoma specialists also consider whether you have other eye conditions, such as cataracts, that might allow us to combine procedures. Treatment plans are individualized, and we reassess the approach at every follow-up visit to confirm that your pressure remains at a safe level.

Many patients maintain stable eye pressure and healthy optic nerves with eye drops as their only treatment, particularly when glaucoma is caught early. However, drops must be used consistently every day to remain effective, and some patients find the routine difficult to maintain long term. If drops alone are not achieving the target pressure or if adherence becomes a challenge, laser treatment or surgery may offer a more reliable path to sustained pressure control.

Eye drops can cause local effects such as redness, stinging, and changes in eyelash growth (with prostaglandins), as well as systemic effects like fatigue or breathing changes (with beta-blockers). Laser procedures may cause temporary inflammation or a short-term pressure spike that is managed with drops. Surgical procedures carry risks including infection, bleeding, and over-correction or under-correction of pressure, though serious complications are uncommon with experienced surgical care.

Follow-up frequency depends on the stability of your condition. Newly diagnosed patients or those who have recently changed treatment may be seen every one to three months. Once pressure is stable and the optic nerve shows no signs of progression, visits can often be spaced to every four to six months. Our team uses OCT imaging and visual field testing at these visits to detect even subtle changes that might prompt a treatment adjustment.